Furthermore, in patients with advanced HF with NYHA functional class IV symptoms, there is a possibility that neprilysin inhibition may result in the potentiation of vasoconstrictive peptides such as angiotensin I and II and endothelin. This evidence concerns the gene MME and hydrops fetalis.